US20160074295A1 - Method for lightening skin with ricinoleic acid - Google Patents

Method for lightening skin with ricinoleic acid Download PDF

Info

Publication number
US20160074295A1
US20160074295A1 US14/948,461 US201514948461A US2016074295A1 US 20160074295 A1 US20160074295 A1 US 20160074295A1 US 201514948461 A US201514948461 A US 201514948461A US 2016074295 A1 US2016074295 A1 US 2016074295A1
Authority
US
United States
Prior art keywords
acid
skin
lightening
composition
lightening skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/948,461
Inventor
Stephen Alan Madison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Conopco Inc
Original Assignee
Conopco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conopco Inc filed Critical Conopco Inc
Priority to US14/948,461 priority Critical patent/US20160074295A1/en
Publication of US20160074295A1 publication Critical patent/US20160074295A1/en
Priority to US16/380,657 priority patent/US20190336424A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the present invention is directed to a skin lightening additive as well as compositions comprising the same. More particularly, the present invention is directed to a cosmetic composition comprising a skin lightening additive whereby the skin lightening additive comprises a heterosubstituted, saturated or unsaturated aliphatic acid, or a mixture thereof.
  • the skin lightening additive when used, results in a cosmetic composition that can provide moisturizing benefits. Moreover, it has been unexpectedly discovered that such aliphatic acids have skin lightening benefits when topically applied.
  • the cosmetic compositions of the present invention preferably comprise, as a lightening additive, compounds like 12-hydroxystearic acid, ricinoleic acid or both.
  • the cosmetic compositions of this invention result in a decrease in melanin content which is at least about 8% lower (preferably, at least about 11% lower) when comparing MelanoDermTM cultures treated with the same to MelanoDerm cultures that have not been subjected to a composition with the newly discovered skin lightening additives of this invention.
  • compositions that comprise, as a lightening additive, a heterosubstituted, saturated or unsaturated aliphatic acid, or mixture thereof.
  • the present invention is directed to a skin lightening additive, the skin lightening additive comprising a heterosubstituted, saturated or unsaturated aliphatic acid, or both.
  • the present invention is directed to a cosmetic composition for skin lightening, the cosmetic composition comprising a skin lightening agent comprising the skin lightening additive of the first aspect of this invention.
  • the present invention is directed to a method for lightening skin with the cosmetic composition of the second aspect of this invention.
  • a decrease in melanin content means a melanin content decrease when comparing two (2), three week old MatTek MelanoDerm cultures that have not been treated with a composition comprising the skin lightening additive of this invention to two (2), three week old MatTek MelanoDerm cultures that have been treated with a composition comprising the skin lightening additive of this invention wherein treated means:
  • Cosmetic composition is meant to include a composition for topical application to skin of mammals, especially humans. Such a composition may be generally classified as leave-on or rinse off, and is meant to include conditioners or tonics, lipsticks, color cosmetics, and general topical compositions that in some fashion and at the very least, reduce the effect of melanin on keratinocytes.
  • Lightening and whitening as used herein are meant to mean the same and they include the lightening of skin directly as well as the lightening of spots on the skin, like age spots and freckles.
  • Dulbecco's Modified Eagle Media means the nutrient solution sold by MatTek Corporation and treated and used according to instructions supplied with the product commercially identified as MEL30010BBLLMM.
  • Skin lightening additive means a component suitable to result in physical, but especially biological whitening (i.e., a reduction in melanin production) whereby the skin lightening additive can comprise, consist essentially of or consist of the skin lightening additive.
  • MelanoDerm means the product having normal, human-derived epidermal keratinocytes and melanocytes which have been cultured to form a multilayered, highly differentiated model of the human epidermis, all of which is made commercially available by MatTek Corporation.
  • Unsaturated, as used herein, means having at least one bond that is not spa hybridized. Comprising, as used herein, is meant to include consisting essentially of and consisting of.
  • the cosmetic composition of the present invention can be in the form of a liquid, lotion, cream, serum, gel, soap bar or toner, or applied via a face mask or patch.
  • the composition of this invention is one that at the very least, lightens skin when skin is meant to include skin on the face, neck, chest, back, arms, hands, legs and scalp. All ranges identified herein are meant to implicitly include all ranges subsumed therein, if, for example, reference to the same is not explicitly made.
  • the only limitation with respect to the skin lightening additive that may be used in this invention is that the same may be used in a topical composition suitable for use on humans.
  • the preferred additive is a heterosubstituted, saturated or unsaturated aliphatic acid or a mixture thereof.
  • the skin lightening additive employed in the present invention comprises a compound having the formulae:
  • the preferred compounds suitable for use in this invention are aleuritic acid; phloionolic acid; 9,10,13-trihydroxy-11-octadecenoic acid; 9,13-dihydroxy-12-ethoxy-10-octadecenoic acid; 9-hydroxy-10,12-octadecadienoic acid; 4,14-dihydroxy-octadecanoic acid; 12-hydroxystearic acid (12-hydroxyoctadecanoic acid); lesquerolic acid; ricinelaidic acid; ambrettolic acid, and rincinoleic acid (12-hydroxy-9-cis-octadecanoic acid) as represented by either formula I or II.
  • Other preferred compounds suitable for use in this invention include beta-dimorphecolic acid; densipolic acid; 8-methoxy-13-hydroxy-9,11-octadecadienoic acid; 7-oxo-octadecanoic acid; 9-oxo-octadecanoic acid; 12-oxo-octadecanoic acid and 10-oxo-14-methyl-pentadecanoic acid as represented by formula III.
  • Such compounds are commercially available from suppliers like Vertellus Specialties, Inc., Welch, Home & Clark Co., Inc., as well as Croda Chemicals.
  • the cosmetic compositions of the present invention typically comprise from about 0.001 to about 15% by weight, and preferably, from about 0.1 to about 12%, and most preferably, from about 1 to about 10% by weight skin lightening additive, based on total weight of the cosmetic composition and including all ranges subsumed therein.
  • the skin lightening additive of this invention comprises from about 0.2 to about 95%, and preferably, from about 10 to about 85%, and most preferably, from about 30 to about 65% by weight heterosubstituted saturated or unsaturated aliphatic acid, or a mixture thereof, based on total weight of skin lightening additive and including all ranges subsumed therein.
  • the cosmetic composition of this invention comprises from about 2 to about 9%, and preferably, from about 3 to 8%, and most preferably, from about 3 to about 6% by weight heterosubstituted, saturated or unsaturated aliphatic acid, or a mixture thereof, based on total weight of the cosmetic composition and including all ranges subsumed therein.
  • the weight ratio of heterosubstituted, saturated or unsaturated aliphatic acid to heterosubstituted, saturated aliphatic acid is from about 5:95 to about 95:5, and preferably, from about 20:80 to about 80:20, and most preferably, from about 40:60 to about 60:40, including all ratios subsumed therein.
  • the cosmetically acceptable vehicle suitable for use in this invention may be aqueous-based, anhydrous or an emulsion whereby a water-in-oil or oil-in-water emulsion is generally preferred. If the use of water is desired, water typically makes up the balance of the cosmetic composition, and preferably, makes up from about 5 to about 99%, and most preferably, from about 40 to about 80% by weight of the cosmetic composition, including all ranges subsumed therein.
  • organic solvents may be optionally included to act as carriers or to assist carriers within the compositions of the present invention.
  • organic solvents suitable for use in the present invention include alkanols like ethyl and isopropyl alcohol, mixtures thereof or the like.
  • ester oils like isopropyl myristate, cetyl myristate, 2-octyldodecyl myristate, avocado oil, almond oil, olive oil, neopentylglycol dicaprate, mixtures thereof or the like.
  • ester oils assist in emulsifying the cosmetic composition of this invention, and an effective amount is often used to yield a stable, and most preferably, water-in-oil emulsion.
  • Emollients may also be used, if desired, as carriers within the cosmetic composition of the present invention.
  • Alcohols like 1-hexadecanol (i.e., cetyl alcohol) and phenoxyethanol are often desired as are the emollients generally classified as silicone oils and synthetic esters.
  • Silicone oils suitable for use include cyclic or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms.
  • Nonvolatile silicone oils useful as an emollient material in the inventive cosmetic composition described herein include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers.
  • the essentially non-volatile polyalkyl siloxanes useful herein include, for example, polydimethylsiloxanes.
  • ester emollients that may optionally be used are:
  • Emollients when used typically make up from about 0.1 to about 50% by weight of the cosmetic composition, including all ranges subsumed therein.
  • Fatty acids having from 10 to 30 carbon atoms may also be included as cosmetically acceptable carriers within the composition of the present invention.
  • Illustrative examples of such fatty acids include pelargonic, lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, arachidic, behenic or erucic acid, and mixtures thereof.
  • Compounds that are believed to enhance skin penetration, like dimethyl sulfoxide, may also be used as an optional carrier.
  • Humectants of the polyhydric alcohol type may also be employed in the cosmetic compositions of this invention.
  • the humectant often aids in increasing the effectiveness of the emollient, reduces scaling, stimulates removal of built-up scale and improves skin feel.
  • Typical polyhydric alcohols include glycerol, polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof.
  • the humectant is preferably propylene glycol or sodium hyaluronate.
  • the amount of humectant may range anywhere from 0.2 to 25%, and preferably, from about 0.5 to about 15% by weight of the cosmetic composition, based on total weight of the cosmetic composition and including all ranges subsumed therein.
  • Thickeners may also be utilized as part of the cosmetically acceptable carrier in the cosmetic compositions of the present invention.
  • Typical thickeners include cross-linked acrylates (e.g. Carbopol 982), hydrophobically-modified acrylates (e.g. Carbopol 1382), cellulosic derivatives and natural gums.
  • useful cellulosic derivatives are sodium carboxymethylcellulose, hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose and hydroxymethyl cellulose.
  • Natural gums suitable for the present invention include guar, xanthan, sclerotium , carrageenan, pectin and combinations of these gums.
  • Amounts of the thickener may range from 0.0 to 5%, usually from 0.001 to 1%, optimally from 0.01 to 0.5% by weight.
  • the water, solvents, silicones, esters, fatty acids, humectants and/or thickeners will constitute the cosmetically acceptable carrier in amounts from 1 to 99.9%, preferably from 80 to 99% by weight.
  • Surfactants may also be present in cosmetic compositions of the present invention. Total concentration of the surfactant will range from about 0 to about 40%, and preferably, from about 0 to about 20%, optimally from about 0 to about 5% by weight of the composition.
  • the surfactant may be selected from the group consisting of anionic, nonionic, cationic and amphoteric actives.
  • nonionic surfactants are those with a C 10 -C 20 fatty alcohol or acid hydrophobe condensed with from 2 to 100 moles of ethylene oxide or propylene oxide per mole of hydrophobe; C 2 -C 10 alkyl phenols condensed with from 2 to 20 moles of alkylene oxide; mono- and di-fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di-C 8 -C 20 fatty acids; block copolymers (ethylene oxide/propylene oxide); and polyoxyethylene sorbitan as well as combinations thereof.
  • Alkyl polyglycosides and saccharide fatty amides are also suitable nonionic surfactants.
  • Preferred anionic surfactants include soap, alkyl ether sulfate and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C 8 -C 20 acyl isothionates, acyl glutamates, C 8 -C 20 alkyl ether phosphates and combinations thereof.
  • Perfumes may be used in the cosmetic composition of this invention.
  • Illustrative non-limiting examples of the types of perfumes that may be used include those comprising terpenes and terpene derivatives like those described in Bauer, K., et al., Common Fragrance and Flavor Materials , VCH Publishers (1990).
  • the amount of fragrance employed in the cosmetic composition of this invention is in the range from about 0.0% to about 10%, more preferably, about 0.00001% to about 5 wt %, most preferably, about 0.0001% to about 2%.
  • Actives are defined as skin benefit agents other than emollients and other than ingredients that merely improve the physical characteristics of the composition. Although not limited to this category, general examples include talcs and silicas, as well as alpha-hydroxy acids, beta-hydroxy acids, peroxides, zinc salts, and sunscreens.
  • Beta-hydroxy acids include salicylic acid, for example.
  • Zinc pyrithione is an example of the zinc salts useful in the cosmetic composition of the present invention.
  • Sunscreens include those materials commonly employed to block ultraviolet light.
  • Illustrative compounds are the derivatives of PABA, cinnamate and salicylate.
  • avobenzophenone Parsol 1789®
  • octyl methoxycinnamate and 2-hydroxy-4-methoxyl benzophenone also known as oxybenzone
  • Octyl methoxycinnamate and 2-hydroxy-4-methoxy benzophenone are commercially available under the trademarks, Parsol MCX and Benzophenone-e, respectively.
  • the exact amount of sunscreen employed in the compositions can vary depending upon the degree of protection desired from the sun's UV radiation. Additives that reflect or scatter the suns rays may also be employed. These additives include oxides like zinc oxide and titanium dioxide.
  • Suitable preservatives include alkyl esters of p-hydroxybenzoic acid, hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds.
  • Particularly preferred preservatives of this invention are methyl paraben, propyl paraben, phenoxyethanol and benzyl alcohol. Preservatives will usually be employed in amounts ranging from about 0.1% to 2% by weight of the composition.
  • Still other optional ingredients that may be used with the cosmetic composition of this invention include dioic acids (e.g., malonic acid, sebacic acid), antioxidants like vitamin E, vitamins, like niacinamide and vitamin C and its derivatives, recorcinols and its derivatives (including those esterified with, for example, ferulic acid, vanillic acid or the like) and retinoids, including retinoic acid, retinal, retinol and retinyl esters, conjugated linoleic acid, petroselinic acid and mixtures thereof, as well as any other conventional ingredients well known for wrinkle-reducing, skin whitening, anti-acne effects and reducing the impact of sebum.
  • dioic acids e.g., malonic acid, sebacic acid
  • antioxidants like vitamin E
  • vitamins like niacinamide and vitamin C and its derivatives
  • recorcinols and its derivatives including those esterified with, for example, ferulic acid, vanillic acid or the
  • the cosmetic compositions of the present invention are intended for use primarily as a product for topical application to human skin, especially and at least as a product for lightening the skin.
  • the described aliphatic acids have excellent skin lightening capabilities whereby the same may be employed as skin lightening additives in topical cosmetic compositions that are applied topically to areas of the skin where lightening or whitening is desired.
  • Other benefits may include skin moisturizing, decreasing the effect of sebum on the skin and skin wrinkle reducing.
  • the cosmetic composition of the present invention has a melting point from about 30° C. to about 45° C., including all ranges subsumed therein.
  • the cosmetic composition of the present invention has a pH from about 4.5 to about 7.5, including all ranges subsumed therein.
  • the desired ingredients are mixed in no particular order and usually at temperatures from about 70 to about 80° C. and under atmospheric pressure.
  • the packaging for the composition of this invention can be a patch, bottle, tube, roll-ball applicator, propellant driven aerosol device, squeeze container or lidded jar.
  • Each treatment condition was done in duplicate and three (3) sets were made for each treatment, as well as for a control (culture not treated with the aliphatic acid).
  • the cultures were maintained at a temperature of about 37° C. and incubated in a humidified, 5% CO 2 incubator during the dosing period, but removed while being dosed.
  • the MelanoDerm cultures were removed and solubilized in a centrifuge tube containing 250 microliters of Solvable reagent (GNE9100, Packard) for sixteen (16) hours (overnight) in a 60° C. oven. Following solubilization, the centrifuge tube containing the sample was spun at 12,000 g for five (5) minutes. Two hundred (200) microliters of supernatant were removed and placed in a ninety-six (96) well plate. A spectrophotometer was used to measure the absorbance of the supernatant at 490 nm. A standard curve using synthetic melanin was set up in parallel to allow quantitation of melanin, in micrograms, of the samples. The results are provided below:

Abstract

Skin lightening additives and skin lightening compositions having at least one of a heterosubstituted, saturated or unsaturated aliphatic acid are described. The compositions are suitable for topical application and comprise ricinoleic acid.

Description

    FIELD OF THE INVENTION
  • The present invention is directed to a skin lightening additive as well as compositions comprising the same. More particularly, the present invention is directed to a cosmetic composition comprising a skin lightening additive whereby the skin lightening additive comprises a heterosubstituted, saturated or unsaturated aliphatic acid, or a mixture thereof. The skin lightening additive, when used, results in a cosmetic composition that can provide moisturizing benefits. Moreover, it has been unexpectedly discovered that such aliphatic acids have skin lightening benefits when topically applied.
  • BACKGROUND OF THE INVENTION
  • Many consumers are concerned with the characteristics of their skin. For example, consumers are concerned with the degree of pigmentation of their skin, freckles and/or age spots. Other consumers wish to reduce skin darkening caused by exposure to sunlight. To meet the needs of consumers, many attempts have been made to develop products that improve skin characteristics. The products developed thus far, however, often tend to have low efficacy, undesirable side effects or both. Furthermore, such products can be expensive and are often not an alternative for lower income consumers.
  • There is an increasing interest to develop a cosmetic composition that comprises new skin lightening additives. This invention, therefore, is directed to cosmetic compositions that comprise new skin lightening additives. The cosmetic compositions of the present invention preferably comprise, as a lightening additive, compounds like 12-hydroxystearic acid, ricinoleic acid or both. The cosmetic compositions of this invention result in a decrease in melanin content which is at least about 8% lower (preferably, at least about 11% lower) when comparing MelanoDerm™ cultures treated with the same to MelanoDerm cultures that have not been subjected to a composition with the newly discovered skin lightening additives of this invention.
  • Additional Information
  • Efforts have been disclosed for making skin care cosmetic compositions. In U.S. Pat. No. 6,875,425, skin lightening agents with 4-substituted resorcinol derivative compounds are described.
  • Other efforts have been disclosed for making skin treatment compositions. In U.S. Pat. Nos. 7,250,158 and 7,247,294, methods for treating with skin lightening agents are described.
  • Still other efforts have been disclosed for treating skin. In U.S. Pat. No. 5,998,423, compositions with polycyclic nitrogen heterocycles are described.
  • None of the additional information above describes skin lightening compositions that comprise, as a lightening additive, a heterosubstituted, saturated or unsaturated aliphatic acid, or mixture thereof.
  • SUMMARY OF THE INVENTION
  • In a first aspect, the present invention is directed to a skin lightening additive, the skin lightening additive comprising a heterosubstituted, saturated or unsaturated aliphatic acid, or both.
  • In a second aspect, the present invention is directed to a cosmetic composition for skin lightening, the cosmetic composition comprising a skin lightening agent comprising the skin lightening additive of the first aspect of this invention.
  • In a third aspect, the present invention is directed to a method for lightening skin with the cosmetic composition of the second aspect of this invention.
  • All other aspects of the present invention will more readily become apparent upon considering the detailed description and examples which follow.
  • As used herein, a decrease in melanin content means a melanin content decrease when comparing two (2), three week old MatTek MelanoDerm cultures that have not been treated with a composition comprising the skin lightening additive of this invention to two (2), three week old MatTek MelanoDerm cultures that have been treated with a composition comprising the skin lightening additive of this invention wherein treated means:
      • (a) placing the MelanoDerm culture within a six (6) well tissue culture dish and set about 0.3 cm off of the tissue culture dish;
      • (b) subjecting the MelanoDerm culture to 0.1 and 5 micromolar compositions having the skin lightening additive of this invention, the composition being one prepared from a 10 millimolar solution of skin lightening additive and carrier (e.g., dimethyl sulfoxide) having been diluted with Dulbecco's Modified Eagle Media; and
      • (c) comparing the treated and untreated cultures by obtaining average melanin content (expressed in micrograms) by extracting melanin from MelanoDerm and obtaining absorbance readings at 490 nm (OD490) using a commercially available spectrophotometer like a Hach Spectrophotometer.
  • Cosmetic composition, as used herein, is meant to include a composition for topical application to skin of mammals, especially humans. Such a composition may be generally classified as leave-on or rinse off, and is meant to include conditioners or tonics, lipsticks, color cosmetics, and general topical compositions that in some fashion and at the very least, reduce the effect of melanin on keratinocytes. Lightening and whitening as used herein are meant to mean the same and they include the lightening of skin directly as well as the lightening of spots on the skin, like age spots and freckles. Dulbecco's Modified Eagle Media means the nutrient solution sold by MatTek Corporation and treated and used according to instructions supplied with the product commercially identified as MEL30010BBLLMM. Skin lightening additive means a component suitable to result in physical, but especially biological whitening (i.e., a reduction in melanin production) whereby the skin lightening additive can comprise, consist essentially of or consist of the skin lightening additive. MelanoDerm means the product having normal, human-derived epidermal keratinocytes and melanocytes which have been cultured to form a multilayered, highly differentiated model of the human epidermis, all of which is made commercially available by MatTek Corporation. Unsaturated, as used herein, means having at least one bond that is not spa hybridized. Comprising, as used herein, is meant to include consisting essentially of and consisting of.
  • The cosmetic composition of the present invention can be in the form of a liquid, lotion, cream, serum, gel, soap bar or toner, or applied via a face mask or patch. The composition of this invention is one that at the very least, lightens skin when skin is meant to include skin on the face, neck, chest, back, arms, hands, legs and scalp. All ranges identified herein are meant to implicitly include all ranges subsumed therein, if, for example, reference to the same is not explicitly made.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The only limitation with respect to the skin lightening additive that may be used in this invention is that the same may be used in a topical composition suitable for use on humans. The preferred additive is a heterosubstituted, saturated or unsaturated aliphatic acid or a mixture thereof.
  • In a most preferred embodiment, the skin lightening additive employed in the present invention comprises a compound having the formulae:
  • Figure US20160074295A1-20160317-C00001
  • or a mixture thereof,
    wherein each R is independently hydrogen, hydroxyl, C1-6 alkoxy, C1-6 alkyl, arylalkyl or an amine, with the proviso that at least one R group comprises a heteroatom; each R1 is independently hydrogen, C1-6 alkoxy, C1-6 alkyl, arylalkyl or an amine; n is an integer from about 7 to about 19; and s and e are each independently an integer from about 0 to about 8, where s+e≧6; q is an integer from about 6 to about 11; each r is independently an integer from 0 to 1, with the proviso that each r is not 1 when x is 1; x is an integer from 0 to 1 with the proviso that x is 0 when at least one r is 1; and each t is independently an integer from 1 to 7.
  • The preferred compounds suitable for use in this invention (either alone or in a mixture) are aleuritic acid; phloionolic acid; 9,10,13-trihydroxy-11-octadecenoic acid; 9,13-dihydroxy-12-ethoxy-10-octadecenoic acid; 9-hydroxy-10,12-octadecadienoic acid; 4,14-dihydroxy-octadecanoic acid; 12-hydroxystearic acid (12-hydroxyoctadecanoic acid); lesquerolic acid; ricinelaidic acid; ambrettolic acid, and rincinoleic acid (12-hydroxy-9-cis-octadecanoic acid) as represented by either formula I or II. Other preferred compounds suitable for use in this invention include beta-dimorphecolic acid; densipolic acid; 8-methoxy-13-hydroxy-9,11-octadecadienoic acid; 7-oxo-octadecanoic acid; 9-oxo-octadecanoic acid; 12-oxo-octadecanoic acid and 10-oxo-14-methyl-pentadecanoic acid as represented by formula III. Furthermore it is within the scope of the present invention to include any derivative (like an ester derivative) and/or salt of the acid represented by formulae I-III, and especially, Mg, Na and/or Ca salts thereof. Such compounds are commercially available from suppliers like Vertellus Specialties, Inc., Welch, Home & Clark Co., Inc., as well as Croda Chemicals.
  • The cosmetic compositions of the present invention typically comprise from about 0.001 to about 15% by weight, and preferably, from about 0.1 to about 12%, and most preferably, from about 1 to about 10% by weight skin lightening additive, based on total weight of the cosmetic composition and including all ranges subsumed therein.
  • While it is within the scope of this invention for the skin lightening additive to consist essentially of and to consist of heterosubstituted, saturated or unsaturated aliphatic acid or a mixture thereof, in an often desired embodiment, the skin lightening additive of this invention comprises from about 0.2 to about 95%, and preferably, from about 10 to about 85%, and most preferably, from about 30 to about 65% by weight heterosubstituted saturated or unsaturated aliphatic acid, or a mixture thereof, based on total weight of skin lightening additive and including all ranges subsumed therein.
  • In yet another desired embodiment, the cosmetic composition of this invention comprises from about 2 to about 9%, and preferably, from about 3 to 8%, and most preferably, from about 3 to about 6% by weight heterosubstituted, saturated or unsaturated aliphatic acid, or a mixture thereof, based on total weight of the cosmetic composition and including all ranges subsumed therein.
  • When used in combination, the weight ratio of heterosubstituted, saturated or unsaturated aliphatic acid to heterosubstituted, saturated aliphatic acid is from about 5:95 to about 95:5, and preferably, from about 20:80 to about 80:20, and most preferably, from about 40:60 to about 60:40, including all ratios subsumed therein.
  • It should be known that commercially acceptable and conventional vehicles may be used, acting as diluents, dispersants and/or carriers for the skin lightening agents and additives described herein and for any other optional but often preferred additives. Therefore, the cosmetically acceptable vehicle suitable for use in this invention may be aqueous-based, anhydrous or an emulsion whereby a water-in-oil or oil-in-water emulsion is generally preferred. If the use of water is desired, water typically makes up the balance of the cosmetic composition, and preferably, makes up from about 5 to about 99%, and most preferably, from about 40 to about 80% by weight of the cosmetic composition, including all ranges subsumed therein.
  • In addition to water, organic solvents may be optionally included to act as carriers or to assist carriers within the compositions of the present invention. Illustrative and non-limiting examples of the types of organic solvents suitable for use in the present invention include alkanols like ethyl and isopropyl alcohol, mixtures thereof or the like.
  • Other optional additives suitable for use include ester oils like isopropyl myristate, cetyl myristate, 2-octyldodecyl myristate, avocado oil, almond oil, olive oil, neopentylglycol dicaprate, mixtures thereof or the like. Typically, such ester oils assist in emulsifying the cosmetic composition of this invention, and an effective amount is often used to yield a stable, and most preferably, water-in-oil emulsion.
  • Emollients may also be used, if desired, as carriers within the cosmetic composition of the present invention. Alcohols like 1-hexadecanol (i.e., cetyl alcohol) and phenoxyethanol are often desired as are the emollients generally classified as silicone oils and synthetic esters. Silicone oils suitable for use include cyclic or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms. Nonvolatile silicone oils useful as an emollient material in the inventive cosmetic composition described herein include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially non-volatile polyalkyl siloxanes useful herein include, for example, polydimethylsiloxanes.
  • The ester emollients that may optionally be used are:
      • (1) Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms. Examples thereof include isoarachidyl neopentanoate, isononyl isonanonoate, oleyl myristate, oleyl stearate, and oleyl oleate.
      • (2) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
      • (3) Polyhydric alcohol esters. Ethylene glycol mono and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters.
      • (4) Wax esters such as beeswax, spermaceti, stearyl stearate and arachidyl behenate.
      • (5) Sterols esters, of which cholesterol fatty acid esters are examples.
  • Emollients when used, typically make up from about 0.1 to about 50% by weight of the cosmetic composition, including all ranges subsumed therein.
  • Fatty acids having from 10 to 30 carbon atoms may also be included as cosmetically acceptable carriers within the composition of the present invention. Illustrative examples of such fatty acids include pelargonic, lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, arachidic, behenic or erucic acid, and mixtures thereof. Compounds that are believed to enhance skin penetration, like dimethyl sulfoxide, may also be used as an optional carrier.
  • Humectants of the polyhydric alcohol type may also be employed in the cosmetic compositions of this invention. The humectant often aids in increasing the effectiveness of the emollient, reduces scaling, stimulates removal of built-up scale and improves skin feel. Typical polyhydric alcohols include glycerol, polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. For best results the humectant is preferably propylene glycol or sodium hyaluronate. The amount of humectant may range anywhere from 0.2 to 25%, and preferably, from about 0.5 to about 15% by weight of the cosmetic composition, based on total weight of the cosmetic composition and including all ranges subsumed therein.
  • Thickeners may also be utilized as part of the cosmetically acceptable carrier in the cosmetic compositions of the present invention. Typical thickeners include cross-linked acrylates (e.g. Carbopol 982), hydrophobically-modified acrylates (e.g. Carbopol 1382), cellulosic derivatives and natural gums. Among useful cellulosic derivatives are sodium carboxymethylcellulose, hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose and hydroxymethyl cellulose. Natural gums suitable for the present invention include guar, xanthan, sclerotium, carrageenan, pectin and combinations of these gums. Amounts of the thickener may range from 0.0 to 5%, usually from 0.001 to 1%, optimally from 0.01 to 0.5% by weight.
  • Collectively, the water, solvents, silicones, esters, fatty acids, humectants and/or thickeners will constitute the cosmetically acceptable carrier in amounts from 1 to 99.9%, preferably from 80 to 99% by weight.
  • Surfactants may also be present in cosmetic compositions of the present invention. Total concentration of the surfactant will range from about 0 to about 40%, and preferably, from about 0 to about 20%, optimally from about 0 to about 5% by weight of the composition. The surfactant may be selected from the group consisting of anionic, nonionic, cationic and amphoteric actives. Particularly preferred nonionic surfactants are those with a C10-C20 fatty alcohol or acid hydrophobe condensed with from 2 to 100 moles of ethylene oxide or propylene oxide per mole of hydrophobe; C2-C10 alkyl phenols condensed with from 2 to 20 moles of alkylene oxide; mono- and di-fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di-C8-C20 fatty acids; block copolymers (ethylene oxide/propylene oxide); and polyoxyethylene sorbitan as well as combinations thereof. Alkyl polyglycosides and saccharide fatty amides (e.g. methyl gluconamides) are also suitable nonionic surfactants.
  • Preferred anionic surfactants include soap, alkyl ether sulfate and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C8-C20 acyl isothionates, acyl glutamates, C8-C20 alkyl ether phosphates and combinations thereof.
  • Perfumes may be used in the cosmetic composition of this invention. Illustrative non-limiting examples of the types of perfumes that may be used include those comprising terpenes and terpene derivatives like those described in Bauer, K., et al., Common Fragrance and Flavor Materials, VCH Publishers (1990).
  • Illustrative yet non-limiting examples of the types of fragrances that may be used in this invention include myrcene, dihydromyrenol, citral, tagetone, cis-geranic acid, citronellic acid, or cis-geranic acid nitrile, mixtures thereof or the like.
  • Preferably, the amount of fragrance employed in the cosmetic composition of this invention is in the range from about 0.0% to about 10%, more preferably, about 0.00001% to about 5 wt %, most preferably, about 0.0001% to about 2%.
  • Various types of optional additional active ingredients may be used in the cosmetic compositions of the present invention. Actives are defined as skin benefit agents other than emollients and other than ingredients that merely improve the physical characteristics of the composition. Although not limited to this category, general examples include talcs and silicas, as well as alpha-hydroxy acids, beta-hydroxy acids, peroxides, zinc salts, and sunscreens.
  • Beta-hydroxy acids include salicylic acid, for example. Zinc pyrithione is an example of the zinc salts useful in the cosmetic composition of the present invention.
  • Sunscreens include those materials commonly employed to block ultraviolet light. Illustrative compounds are the derivatives of PABA, cinnamate and salicylate. For example, avobenzophenone (Parsol 1789®) octyl methoxycinnamate and 2-hydroxy-4-methoxyl benzophenone (also known as oxybenzone) can be used. Octyl methoxycinnamate and 2-hydroxy-4-methoxy benzophenone are commercially available under the trademarks, Parsol MCX and Benzophenone-e, respectively. The exact amount of sunscreen employed in the compositions can vary depending upon the degree of protection desired from the sun's UV radiation. Additives that reflect or scatter the suns rays may also be employed. These additives include oxides like zinc oxide and titanium dioxide.
  • Many cosmetic compositions, especially those containing water, should be protected against the growth of potentially harmful microorganisms. Anti-microbial compounds, such as triclosan, and preservatives are, therefore, typically necessary. Suitable preservatives include alkyl esters of p-hydroxybenzoic acid, hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Particularly preferred preservatives of this invention are methyl paraben, propyl paraben, phenoxyethanol and benzyl alcohol. Preservatives will usually be employed in amounts ranging from about 0.1% to 2% by weight of the composition.
  • Still other optional ingredients that may be used with the cosmetic composition of this invention include dioic acids (e.g., malonic acid, sebacic acid), antioxidants like vitamin E, vitamins, like niacinamide and vitamin C and its derivatives, recorcinols and its derivatives (including those esterified with, for example, ferulic acid, vanillic acid or the like) and retinoids, including retinoic acid, retinal, retinol and retinyl esters, conjugated linoleic acid, petroselinic acid and mixtures thereof, as well as any other conventional ingredients well known for wrinkle-reducing, skin whitening, anti-acne effects and reducing the impact of sebum.
  • The cosmetic compositions of the present invention are intended for use primarily as a product for topical application to human skin, especially and at least as a product for lightening the skin. Thus, the inventor has discovered that the described aliphatic acids have excellent skin lightening capabilities whereby the same may be employed as skin lightening additives in topical cosmetic compositions that are applied topically to areas of the skin where lightening or whitening is desired. Other benefits may include skin moisturizing, decreasing the effect of sebum on the skin and skin wrinkle reducing. Often, the cosmetic composition of the present invention has a melting point from about 30° C. to about 45° C., including all ranges subsumed therein. In an especially preferred embodiment, the cosmetic composition of the present invention has a pH from about 4.5 to about 7.5, including all ranges subsumed therein.
  • When making the cosmetic composition of the present invention, the desired ingredients are mixed in no particular order and usually at temperatures from about 70 to about 80° C. and under atmospheric pressure.
  • The packaging for the composition of this invention can be a patch, bottle, tube, roll-ball applicator, propellant driven aerosol device, squeeze container or lidded jar.
  • The examples which follow are provided to illustrate and facilitate an understanding of the invention. The examples are not intended to limit the scope of the claims.
  • Examples
  • Commercially available human skin equivalents (MelanoDerm™ from MatTek) were obtained for testing the impact of heterosubstituted, saturated or unsaturated aliphatic acid on melanogenesis. Solutions having a final concentration of 0.1 to 5 micromolar were prepared from a 10 millimolar dimethyl sulfoxide stock solution and dosed ten (10) times in a three (3) week period into the media of the MelanoDerm cultures. The media consisted of commercially available basal Dulbecco's Modified Eagles media, prepared and treated in the manner set forth in the manufacturer's instructions. For long term maintenance of the MelanoDerms, the basal media was supplemented with bFGF and alpha MSH to stimulate melanocyte growth and melanogenesis. Each treatment condition was done in duplicate and three (3) sets were made for each treatment, as well as for a control (culture not treated with the aliphatic acid). The cultures were maintained at a temperature of about 37° C. and incubated in a humidified, 5% CO2 incubator during the dosing period, but removed while being dosed.
  • After a three (3) week period, the MelanoDerm cultures were removed and solubilized in a centrifuge tube containing 250 microliters of Solvable reagent (GNE9100, Packard) for sixteen (16) hours (overnight) in a 60° C. oven. Following solubilization, the centrifuge tube containing the sample was spun at 12,000 g for five (5) minutes. Two hundred (200) microliters of supernatant were removed and placed in a ninety-six (96) well plate. A spectrophotometer was used to measure the absorbance of the supernatant at 490 nm. A standard curve using synthetic melanin was set up in parallel to allow quantitation of melanin, in micrograms, of the samples. The results are provided below:
  • TABLES
    Active MC* Value Range Average MC ΔMC
    Control 76.0-78.4 77.2
    Aliphatic acidi 67.9-69.2 68.6 8.6
    Active MC Value Range Average MC ΔMC
    Control 76.0-78.4 77.2
    Aliphatic acidii 69.9-67.6 68.8 8.4
    i= ricinoleic acid (0.1 uM)
    ii= 12-hydroxystearic acid (5 uM)
    *MC = melanin content
  • The results, as they relate to MelanoDerm cultures, show that cosmetic compositions with the aliphatic acids of this invention unexpectedly result in skin lightening.

Claims (12)

1-19. (canceled)
20-51. (canceled)
52. A method for lightening skin comprising the steps of:
(a) identifying skin in need of lightening
(b) contacting the skin with a composition comprising ricinoleic acid; and
(c) lightening skin,
wherein the composition lightens skin with ricinoleic acid and the composition is an emulsion.
53. The method for lightening skin according to claim 52 wherein the composition further comprises 12-hydroxystearic acid, niacinamide or both.
54. The method for lightening skin according to claim 52 wherein the composition further comprises octylmethoxycinnamate, avobenzophenone, or both.
55. The method for lightening skin according to claim 52 wherein the composition further comprises a resorcinol, retinoid or both.
56. The method for lightening skin according to claim 52 wherein the composition further comprises zinc oxide, zinc pyrithione or both.
57. The method for lightening skin according to claim 52 wherein the composition further comprises phenoxyethanol.
58. The method for lightening skin according to claim 52 wherein the composition further comprises conjugated linoleic acid, petroselinic acid or both.
59. The method for lightening skin according to claim 52 wherein the composition comprises from about 0.001 to 15% by weight ricinoleic acid.
60. The method for lightening skin according to claim 52 wherein the composition further comprises stearic acid.
61. The method for lightening skin according to claim 52 wherein the composition further comprises salicylic acid.
US14/948,461 2008-06-18 2015-11-23 Method for lightening skin with ricinoleic acid Abandoned US20160074295A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US14/948,461 US20160074295A1 (en) 2008-06-18 2015-11-23 Method for lightening skin with ricinoleic acid
US16/380,657 US20190336424A1 (en) 2008-06-18 2019-04-10 Method for lightening skin with ricinoleic acid

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/141,561 US20090317341A1 (en) 2008-06-18 2008-06-18 Compositions for Lightening Skin Color
US12/908,248 US9227090B2 (en) 2008-06-18 2010-10-20 Method for lightening skin
US14/948,461 US20160074295A1 (en) 2008-06-18 2015-11-23 Method for lightening skin with ricinoleic acid

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/908,248 Continuation US9227090B2 (en) 2008-06-18 2010-10-20 Method for lightening skin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/380,657 Continuation US20190336424A1 (en) 2008-06-18 2019-04-10 Method for lightening skin with ricinoleic acid

Publications (1)

Publication Number Publication Date
US20160074295A1 true US20160074295A1 (en) 2016-03-17

Family

ID=41120037

Family Applications (4)

Application Number Title Priority Date Filing Date
US12/141,561 Abandoned US20090317341A1 (en) 2008-06-18 2008-06-18 Compositions for Lightening Skin Color
US12/908,248 Active US9227090B2 (en) 2008-06-18 2010-10-20 Method for lightening skin
US14/948,461 Abandoned US20160074295A1 (en) 2008-06-18 2015-11-23 Method for lightening skin with ricinoleic acid
US16/380,657 Abandoned US20190336424A1 (en) 2008-06-18 2019-04-10 Method for lightening skin with ricinoleic acid

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US12/141,561 Abandoned US20090317341A1 (en) 2008-06-18 2008-06-18 Compositions for Lightening Skin Color
US12/908,248 Active US9227090B2 (en) 2008-06-18 2010-10-20 Method for lightening skin

Family Applications After (1)

Application Number Title Priority Date Filing Date
US16/380,657 Abandoned US20190336424A1 (en) 2008-06-18 2019-04-10 Method for lightening skin with ricinoleic acid

Country Status (19)

Country Link
US (4) US20090317341A1 (en)
EP (3) EP3103434B1 (en)
JP (1) JP5620908B2 (en)
KR (2) KR101788998B1 (en)
CN (3) CN102065829B (en)
AR (1) AR072165A1 (en)
AU (1) AU2009259483B2 (en)
BR (1) BRPI0914843B1 (en)
CA (1) CA2728978C (en)
CL (1) CL2010001461A1 (en)
EA (2) EA026945B1 (en)
ES (2) ES2511916T3 (en)
HK (2) HK1153954A1 (en)
MX (1) MX2010014098A (en)
PL (2) PL2752184T3 (en)
SA (1) SA109300373B1 (en)
TW (1) TWI442943B (en)
WO (1) WO2009153169A1 (en)
ZA (1) ZA201008792B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070098824A1 (en) 2005-10-27 2007-05-03 Kgk Synergize Inc. Canola extracts containing high levels of phenolic acids
US20090317341A1 (en) * 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
WO2011137563A1 (en) 2010-05-07 2011-11-10 Unilever Plc High solvent content emulsions
JP5866372B2 (en) 2010-11-11 2016-02-17 ユニリーバー・ナームローゼ・ベンノートシヤープ Leave-on non-solid skin conditioning composition containing 12-hydroxystearic acid
US20120122936A1 (en) * 2010-11-11 2012-05-17 Conopco, Inc., D/B/A Unilever Leave-on nonsolid skin conditioning compositions containing 12-[(12-hydroxyoctadecanoyl)oxy] octadecanoic acid
US8613939B2 (en) 2010-12-15 2013-12-24 Conopco, Inc. Leave-on nonsolid skin conditioning compositions containing 12-hydroxystearic acid and ethoxylated hydrogenated castor oil
DE102010056550A1 (en) 2010-12-30 2012-07-05 Evonik Goldschmidt Gmbh Use of 13-hydroxy-9,11-octadecadienoic acid for tanning human skin
US20120214871A1 (en) * 2011-02-17 2012-08-23 Conopco, Inc., D/B/A Unilever Leave-on nonsolid oil-continuous skin conditioning compositions containing 12-hydroxystearic acid
BR112014009501B1 (en) 2011-11-11 2018-08-28 Unilever Nv organogel and cosmetic composition
EP2604248B1 (en) 2011-12-13 2017-10-25 Unilever PLC Oil-in-water cosmetic composition
EP2934458B2 (en) 2012-12-20 2023-02-22 Unilever Global IP Limited Eutectic mixtures in personal care compositions
US10172772B2 (en) * 2013-01-31 2019-01-08 KGK Science, Inc. Methods of skin whitening by use of canola extracts
CA2926217C (en) * 2013-10-24 2018-03-27 The Procter & Gamble Company Skin lightening cosmetic compositions and methods
CN107072936A (en) 2015-08-10 2017-08-18 玫琳凯有限公司 Topical compositions
EP3359261B1 (en) 2015-10-05 2019-05-15 Unilever NV A skin lightening composition
WO2017108438A1 (en) * 2015-12-22 2017-06-29 Unilever Plc Hydroxy functionalized solvent based skin benefit composition
JP6834086B2 (en) * 2016-04-13 2021-02-24 ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. 10-Hydroxystearic acid composition
BR112018077141B1 (en) * 2016-07-27 2022-02-01 Unilever Ip Holdings B.V. Personal care composition and uses of a skin care composition
WO2018113637A1 (en) * 2016-12-21 2018-06-28 Unilever Plc Personal care compositions with glutathione precursor comprising nicotinamide and amino acids
EP3558246B1 (en) 2016-12-21 2021-10-20 Unilever IP Holdings B.V. Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
JP7082623B2 (en) 2016-12-21 2022-06-08 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Composition for personal care with cystine
CN110121329B (en) * 2016-12-21 2022-04-12 联合利华知识产权控股有限公司 Topical skin lightening additives and compositions with amino acids and PPAR-activated fatty acids
EA038885B1 (en) * 2016-12-21 2021-11-02 ЮНИЛЕВЕР АйПи ХОЛДИНГС Б.В. Topical skin lightening additive and composition with amino acids and nicotinamide compounds
CN110121331B (en) 2016-12-21 2022-09-16 联合利华知识产权控股有限公司 Personal care compositions containing poorly soluble compounds
US11701322B2 (en) 2018-03-23 2023-07-18 Mary Kay Inc. Topical compositions and methods
CN111110607B (en) * 2020-02-26 2020-12-15 李应坤 Mild moisturizing type foam facial cleanser and preparation method thereof
MX2023001280A (en) * 2020-07-30 2023-03-06 Unilever Ip Holdings B V A personal care composition comprising atractylenolide-i or a source thereof.
EP4023237A1 (en) * 2020-12-30 2022-07-06 Galaxy Surfactants Ltd. Personal and home care compositions comprising fatty acids from tung seed oil as antimicrobial preservative
TW202308589A (en) * 2021-04-22 2023-03-01 美商Glo製藥公司 Skin peel compositions
WO2023061962A1 (en) 2021-10-13 2023-04-20 Unilever Ip Holdings B.V. A personal care composition comprising vitamin k2 and hydroxystearic acid
WO2023151986A1 (en) 2022-02-09 2023-08-17 Unilever Ip Holdings B.V. A skin brightening composition

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05201847A (en) * 1992-01-28 1993-08-10 Sunstar Inc Skin-beautifying cosmetic
US5262153A (en) * 1989-09-20 1993-11-16 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkujo Skin-whitening agent
US5389677A (en) * 1986-12-23 1995-02-14 Tristrata Inc Method of treating wrinkles using glycalic acid
US6423325B1 (en) * 1999-07-30 2002-07-23 Conopco, Inc. Skin care composition
US8247405B2 (en) * 2008-12-10 2012-08-21 Conopco, Inc. Skin lightening compositions with acetylcholinesterase inhibitors
US9227090B2 (en) * 2008-06-18 2016-01-05 Conopco, Inc. Method for lightening skin

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533119A (en) * 1975-04-10 1978-11-22 Unilever Ltd Skin lightening compositions
JPS63115809A (en) * 1986-10-31 1988-05-20 Kanebo Ltd Skin cosmetic
IN169917B (en) 1989-03-21 1992-01-11 Lever Hindustan Ltd
JPH05345705A (en) 1992-02-03 1993-12-27 Nippon Shinyaku Co Ltd Skin-beautifying cosmetic composition
JPH05306231A (en) 1992-04-24 1993-11-19 Pola Chem Ind Inc Skin external preparation
CA2135386C (en) * 1992-05-12 1998-08-18 Brian D. Hofrichter Antiperspirant gel stick composition
US5399785A (en) * 1992-08-05 1995-03-21 Nippon Paint Co., Ltd. Tyrosinase activity inhibitor
JP3480952B2 (en) 1992-08-17 2003-12-22 株式会社コーセー External preparation for skin
JPH06227939A (en) * 1993-02-05 1994-08-16 Yuka Sangyo Kk Cosmetic
US5591424A (en) * 1993-06-30 1997-01-07 The Procter & Gamble Company Antiperspirant gel stick compositions
JPH0725742A (en) 1993-07-15 1995-01-27 Kao Corp Fair-skinning cosmetic
JP3025605B2 (en) 1993-07-21 2000-03-27 花王株式会社 Whitening cosmetics
JPH07238010A (en) * 1994-02-24 1995-09-12 Kanebo Ltd Skin cosmetic
US5516511A (en) * 1994-05-06 1996-05-14 The Procter & Gamble Company Antiperspirant gel compositions comprising chelators
JP3696271B2 (en) 1994-09-22 2005-09-14 花王株式会社 Whitening cosmetics
JPH0892055A (en) 1994-09-22 1996-04-09 Kao Corp Whitening cosmetic
FR2735688B1 (en) * 1995-06-26 1997-08-14 Oreal USE IN COMBINATION OF AN ALPHA-HYDROXYACID AND A TITANIUM OXIDE FOR SKIN WHITENING
JPH0987135A (en) 1995-07-13 1997-03-31 Shiseido Co Ltd Dermal preparation for external use
JPH0952817A (en) 1995-08-09 1997-02-25 Kao Corp Beautifying and whitening cosmetic
JP3645633B2 (en) 1995-12-13 2005-05-11 花王株式会社 Whitening cosmetics
JPH09268118A (en) * 1996-04-01 1997-10-14 Kao Corp Skin color-improving beautifier
GR1002807B (en) * 1996-06-20 1997-11-13 Lavipharm A.E. Device for topical treatment of acne and method of manufacture.
US5998423A (en) * 1996-10-08 1999-12-07 Therasys, Inc. Methods for modulating melanin production
US5776494A (en) * 1996-12-20 1998-07-07 The Procter & Gamble Company Pharmaceuticals compositions containing gellants in the form of alkyl amides of di-and tri-carboxylic acids
US5744130A (en) * 1996-12-20 1998-04-28 The Procter & Gamble Company Antiperspirant gel-solid stick compositions substantially free of select polar solvents
US6171601B1 (en) * 1996-12-20 2001-01-09 The Procter & Gamble Company Low residue antiperspirant gel-solid stick compositions
JPH10203921A (en) 1997-01-20 1998-08-04 Shiseido Co Ltd Skin preparation for external use
US5863546A (en) * 1997-03-02 1999-01-26 Swinehart; James M Cosmetic composition
JPH10265322A (en) 1997-03-19 1998-10-06 Shiseido Co Ltd Skin preparation for external use
JPH10265321A (en) 1997-03-19 1998-10-06 Shiseido Co Ltd Skin preparation for external use
JP3592918B2 (en) 1997-05-14 2004-11-24 花王株式会社 Cosmetics
US6090369A (en) * 1997-06-04 2000-07-18 Stewart; Ernest Glading Sunscreen formulation with avobenzone and method for stabilizing sunscreen formulation which contains avobenzone
US5965113A (en) * 1997-06-23 1999-10-12 Procter & Gamble Company Low residue antiperspirant gel-solid stick compositions containing volatile nonpolar hydrocarbon solvents
RO118174B1 (en) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Nail polish and use thereof
JPH11124308A (en) 1997-10-22 1999-05-11 Kao Corp Cosmetic
AR017859A1 (en) * 1997-12-15 2001-10-24 Unilever Nv A COSMETIC COMPOSITION TO CLEAR THE SKIN, OF TOPICAL APPLICATION ON HUMAN SKIN AND A COSMETIC METHOD TO CLEAR UP THE SKIN THAT UNDERSTANDS THE TOPICAL APPLICATION ON THE SAME OF SUCH COMPOSITION
JPH11246343A (en) 1998-02-27 1999-09-14 Shiseido Co Ltd Preparation for external use for skin bleaching
US5968489A (en) * 1998-05-01 1999-10-19 The Procter & Gamble Company Antiperspirant composition containing 1,2-hexanediol
US6033651A (en) * 1998-06-10 2000-03-07 Revlon Consumer Products Corporation Gel cosmetic compositions
JP2000143479A (en) 1998-11-05 2000-05-23 Kao Corp Skin-bleaching cosmetic
US6171581B1 (en) * 1998-12-18 2001-01-09 Revlon Consumer Products Corporation Water and oil emulsion solid antiperspirant/deodorant compositions
US6365137B1 (en) * 1999-04-06 2002-04-02 Collaborative Laboratories, Inc. Skin whitening agents
JP2000302661A (en) 1999-04-21 2000-10-31 Kao Corp Cosmetic
US6183730B1 (en) * 1999-05-18 2001-02-06 The Procter & Gamble Company Antiperspirant and deodorant compositions containing cyclohexasiloxane
GB2356386A (en) * 1999-11-17 2001-05-23 Tagra Biotechnologies Ltd Microencapsulation
JP2001163755A (en) 1999-12-07 2001-06-19 Shiseido Co Ltd Preparation for external use for skin
WO2001041730A1 (en) * 1999-12-10 2001-06-14 Unilever Plc Cosmetic compositions and methods for lightening the skin
US20020192243A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
JP2001181173A (en) 1999-12-27 2001-07-03 Kose Corp Bleaching preparation for external use
US6967023B1 (en) * 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
JP2001206833A (en) 2000-01-25 2001-07-31 Kao Corp Cosmetic
GB0006867D0 (en) * 2000-03-21 2000-05-10 Unilever Plc Method and composition for skin lightening
DE10021056A1 (en) * 2000-04-28 2001-10-31 Henkel Kgaa Anhydrous antiperspirants, used for application to the skin, comprises a combination of particulate polysaccharides and/or derivatives, an astringent and a lipid component all contained in a liquid carrier
US6352688B1 (en) * 2000-05-17 2002-03-05 The Procter & Gamble Company High efficacy, low residue antiperspirant stick compositions
JP2004501952A (en) * 2000-06-30 2004-01-22 ユニリーバー・ナームローゼ・ベンノートシヤープ Skin conditioning composition comprising a compound for mimicking the effect of retinoic acid on the skin
US6881414B2 (en) * 2000-11-22 2005-04-19 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Mild cosmetic composition with stabilized retinoids
DE10059239A1 (en) * 2000-11-29 2002-06-06 Cognis Deutschland Gmbh Cosmetic and / or pharmaceutical emulsions
JP2002179516A (en) 2000-12-13 2002-06-26 Pola Chem Ind Inc Skin-whitening composition
US6680285B2 (en) * 2000-12-21 2004-01-20 Unilever Home & Personal Care Usa A Division Of Conopco, Inc. Skin cleansing bar with high levels of liquid emollient
JP2002265387A (en) 2001-03-06 2002-09-18 Kose Corp Skin care preparation
JP2002284664A (en) 2001-03-29 2002-10-03 Shiseido Co Ltd External skin preparation for whitening
GB0114848D0 (en) * 2001-06-18 2001-08-08 Unilever Plc Antiperspirant or deodorant compositions
GB0119583D0 (en) * 2001-08-10 2001-10-03 Unilever Plc Cosmetic composition and method of treating skin
JP3934371B2 (en) 2001-08-15 2007-06-20 玲子 渡久地 Beauty soap
JP2003128521A (en) 2001-10-16 2003-05-08 Rohto Pharmaceut Co Ltd External preparation
EP1340486A1 (en) * 2002-03-01 2003-09-03 Cognis France S.A. Use of sugar esters
JP2003306419A (en) 2002-04-16 2003-10-28 Nikko Chemical Co Ltd Cosmetic
US6835373B2 (en) * 2002-07-12 2004-12-28 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
MXPA05000970A (en) 2002-07-25 2005-06-08 Amcol International Corp Viscous compositions containing hydrophobic liquids.
DE10238449A1 (en) 2002-08-22 2004-03-04 Beiersdorf Ag Cosmetic and / or dermatological preparation
JP2004075645A (en) 2002-08-22 2004-03-11 Kanebo Ltd Cosmetic
JP2004115381A (en) 2002-09-24 2004-04-15 Shiseido Co Ltd External preparation for skin
US20040081672A1 (en) * 2002-10-25 2004-04-29 Gupta Shyam K. Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US6936242B2 (en) * 2002-11-15 2005-08-30 The Gillette Company Multi-portion antiperspirant composition
US6875425B2 (en) * 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
JP2004238394A (en) 2003-01-17 2004-08-26 Kose Corp Rebound inhibitor and skin care preparation for external use containing the same
JP2004262853A (en) 2003-03-03 2004-09-24 Kanebo Ltd Cosmetic
US20040208902A1 (en) * 2003-04-18 2004-10-21 Gupta Shyam K. Controlled-release nano-diffusion delivery systems for cosmetic and pharmaceutical compositions
JP2005002050A (en) 2003-06-12 2005-01-06 Shiseido Co Ltd Bleaching agent and skin care preparation for external use formulated therewith
DE102004055291A1 (en) * 2003-12-09 2005-07-14 Merck Patent Gmbh Colored flake-form effect pigments for use in preparing, e.g. cosmetic composition, comprise layer(s) containing colorant(s) and groove or grid structure
TW200607529A (en) 2004-07-28 2006-03-01 Cream Holdings Pty Ltd Natural sunscreen composition
WO2006036557A1 (en) * 2004-09-24 2006-04-06 Lipo Chemicals, Inc. Delivery system for topically applied compounds
US20060067960A1 (en) * 2004-09-30 2006-03-30 Russ Julio G Color cosmetic compositions
GB0425945D0 (en) * 2004-11-26 2004-12-29 Unilever Plc Underarm cosmetic method and compositions
JP2006219423A (en) 2005-02-10 2006-08-24 Kao Corp Skin cosmetic
WO2006103091A1 (en) * 2005-03-31 2006-10-05 Unilever Plc Enhanced delivery of skin benefit agents
CN101146509B (en) * 2005-03-31 2012-10-10 荷兰联合利华有限公司 Enhanced delivery of skin benefit agents
WO2006117055A1 (en) 2005-05-03 2006-11-09 Unilever Plc Skin lightening composition comprising a conjugated linoleic acid and niacinamide
WO2007039058A2 (en) 2005-09-23 2007-04-12 Dsm Ip Assets B.V. Use of opioid receptor antagonists
US7250158B1 (en) * 2006-03-30 2007-07-31 Conopco, Inc. Skin lightening agents, compositions and methods
US7247294B1 (en) * 2006-03-30 2007-07-24 Conopco, Inc. Skin lightening agents, compositions and methods
ITBA20060049A1 (en) 2006-08-02 2008-02-03 Pierre S R L FOOD SUPPLEMENT BASED ON BIOLOGICAL LYCOPENE AND PROCEDURE FOR OBTAINING BIOLOGICAL LICOPENE.
JP2008150314A (en) 2006-12-18 2008-07-03 Shiseido Co Ltd Bleaching agent
TWI454261B (en) 2007-01-09 2014-10-01 Unigen Inc Chromones as therapeutic agents
KR100823533B1 (en) 2007-02-27 2008-04-30 바이오스펙트럼 주식회사 COMPOSITIONS FOR IMPROVING SKIN CONDITIONS COMPRISING alpha;-BISABOLOL AS AN ACTIVE INGREDIENT

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389677A (en) * 1986-12-23 1995-02-14 Tristrata Inc Method of treating wrinkles using glycalic acid
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
US5262153A (en) * 1989-09-20 1993-11-16 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkujo Skin-whitening agent
JPH05201847A (en) * 1992-01-28 1993-08-10 Sunstar Inc Skin-beautifying cosmetic
US6423325B1 (en) * 1999-07-30 2002-07-23 Conopco, Inc. Skin care composition
US9227090B2 (en) * 2008-06-18 2016-01-05 Conopco, Inc. Method for lightening skin
US8247405B2 (en) * 2008-12-10 2012-08-21 Conopco, Inc. Skin lightening compositions with acetylcholinesterase inhibitors

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Ahn et al. Dermatol Surg. 2006; 32(3): abstract. *
Kapadia et al. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Frontiers in Bioscience. 2008; 13: Tables 1 and 2 *
Kapadia et al. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Frontiers in Bioscience. 2008; 13: Tables 1 and 2. *
Wiechers et al. A new mechanism of action for skin whitening agents: binding to the peroxisome proliferator-actiivated receptor. Int J Cosmet Sci. 2005; 27(2): abstract. *
Wiechers et al. A new mechanism of action for skin whitening agents: binding to the peroxisome proliferator-activated receptor. Int J Cosmet Sci. 2005; 27(2): abstract. *
Wineski et al. Acta Anat (Basel). 1989; 136(2): abstract. *

Also Published As

Publication number Publication date
EP2285342B1 (en) 2014-08-06
PL2752184T3 (en) 2017-05-31
EP2285342B9 (en) 2014-11-26
AU2009259483A1 (en) 2009-12-23
TW201002361A (en) 2010-01-16
EP2752184A3 (en) 2014-12-03
PL2285342T3 (en) 2015-01-30
ZA201008792B (en) 2012-02-29
ES2611791T3 (en) 2017-05-10
KR20110028286A (en) 2011-03-17
US9227090B2 (en) 2016-01-05
EP2285342A1 (en) 2011-02-23
KR101617478B1 (en) 2016-05-02
KR20160049058A (en) 2016-05-04
EP2752184A2 (en) 2014-07-09
CN103976889A (en) 2014-08-13
EA201170042A1 (en) 2011-06-30
CA2728978C (en) 2016-11-15
EA026945B1 (en) 2017-06-30
WO2009153169A1 (en) 2009-12-23
US20090317341A1 (en) 2009-12-24
EP3103434B1 (en) 2019-12-04
US20190336424A1 (en) 2019-11-07
CL2010001461A1 (en) 2011-06-24
ES2511916T3 (en) 2014-10-23
CN102065829A (en) 2011-05-18
SA109300373B1 (en) 2014-03-12
BRPI0914843A2 (en) 2020-12-08
EP3103434A1 (en) 2016-12-14
MX2010014098A (en) 2011-03-21
AR072165A1 (en) 2010-08-11
HK1153954A1 (en) 2012-04-20
CA2728978A1 (en) 2009-12-23
EA018806B1 (en) 2013-10-30
AU2009259483B2 (en) 2013-05-23
CN108158836A (en) 2018-06-15
BRPI0914843B1 (en) 2021-05-04
EA201300756A1 (en) 2014-03-31
US20110033404A1 (en) 2011-02-10
JP5620908B2 (en) 2014-11-05
KR101788998B1 (en) 2017-10-20
TWI442943B (en) 2014-07-01
EP2752184B1 (en) 2016-10-19
HK1200737A1 (en) 2015-08-14
JP2011524393A (en) 2011-09-01
CN103976889B (en) 2017-12-08
CN102065829B (en) 2014-06-04

Similar Documents

Publication Publication Date Title
US9227090B2 (en) Method for lightening skin
US8247405B2 (en) Skin lightening compositions with acetylcholinesterase inhibitors
US20100034763A1 (en) Skin Lightening Composition Comprising CO2 Extracts
EP3509566B1 (en) Compounds for reducing cellular melanin content
AU2013202356B2 (en) Compositions for lightening skin color
US20100158829A1 (en) Method and Composition for Color Modulation
US20070183995A1 (en) Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
US11419803B2 (en) Skin darkening composition
US11433012B2 (en) Peptides for increasing melanin in melanocytes

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION